Vancomycin Injectable Solution Recalled Due to Lack of Sterility Assurance
Apollo Care, LLC is recalling 413 bags of Vancomycin 2g injectable solution (Lot #AC-016638, expiration 05/27/2023) distributed in Missouri due to lack of assurance of sterility.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a Class II drug recall for an injectable medication due to lack of sterility assurance. While the source does not report any illnesses or hospitalizations, non-sterile injectables present a significant risk of infection and contamination. This ranks as High severity per the rubric criterion for risk-of-harm products where injury has not yet been reported.
Plain-English summary
Apollo Care, LLC is recalling Vancomycin 2g added to 500 mL of 0.9% Sodium Chloride Injection (NDC 71170-204-50). The affected lot is AC-016638 with an expiration date of 05/27/2023. The product was distributed in Missouri. A total of 413 bags have been recalled.
The recall was initiated due to a lack of assurance of sterility. Injectable medications that are not sterile can pose serious health risks to patients.
Patients who received this product should contact their healthcare provider. Healthcare providers should discontinue use of this product and contact the manufacturer regarding return procedures.
The recalled product
- Product
- VANComycin 2g added to 500 mL of 0.9% Sodium Chloride Injection, Rx Only. Apollo Care, LLC, 3801 Mojave Ct., Suite 101, Columbia, MO 65202. NDC 71170-204-50
- Manufacturer
- Apollo Care, LLC
- Category
- Drug — Injectable
- Hazard
- lack-of-sterility
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: AC-016638
- Exp. Date 05/27/2023
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27